JP2019524732A5 - - Google Patents

Download PDF

Info

Publication number
JP2019524732A5
JP2019524732A5 JP2019501630A JP2019501630A JP2019524732A5 JP 2019524732 A5 JP2019524732 A5 JP 2019524732A5 JP 2019501630 A JP2019501630 A JP 2019501630A JP 2019501630 A JP2019501630 A JP 2019501630A JP 2019524732 A5 JP2019524732 A5 JP 2019524732A5
Authority
JP
Japan
Prior art keywords
methyl
thiazol
methoxy
methylquinoxalin
carbamate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019501630A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019524732A (ja
JP6903732B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/041880 external-priority patent/WO2018013776A1/en
Publication of JP2019524732A publication Critical patent/JP2019524732A/ja
Publication of JP2019524732A5 publication Critical patent/JP2019524732A5/ja
Application granted granted Critical
Publication of JP6903732B2 publication Critical patent/JP6903732B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019501630A 2016-07-14 2017-07-13 Par4阻害剤としての三環式ヘテロアリール置換のキノリンおよびアザキノリン化合物 Active JP6903732B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662362121P 2016-07-14 2016-07-14
US62/362,121 2016-07-14
PCT/US2017/041880 WO2018013776A1 (en) 2016-07-14 2017-07-13 Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as par4 inhibitors

Publications (3)

Publication Number Publication Date
JP2019524732A JP2019524732A (ja) 2019-09-05
JP2019524732A5 true JP2019524732A5 (enExample) 2020-08-06
JP6903732B2 JP6903732B2 (ja) 2021-07-14

Family

ID=59384259

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019501630A Active JP6903732B2 (ja) 2016-07-14 2017-07-13 Par4阻害剤としての三環式ヘテロアリール置換のキノリンおよびアザキノリン化合物

Country Status (7)

Country Link
US (3) US20190315774A1 (enExample)
EP (1) EP3484894B1 (enExample)
JP (1) JP6903732B2 (enExample)
KR (1) KR102468661B1 (enExample)
CN (1) CN109689664B (enExample)
ES (1) ES2823127T3 (enExample)
WO (1) WO2018013776A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10730868B2 (en) 2016-07-14 2020-08-04 Bristol-Myers Squibb Company Bicyclic heteroaryl substituted compounds
JP7102388B2 (ja) 2016-07-14 2022-07-19 ブリストル-マイヤーズ スクイブ カンパニー 単環式ヘテロアリール置換化合物
JP6903732B2 (ja) 2016-07-14 2021-07-14 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company Par4阻害剤としての三環式ヘテロアリール置換のキノリンおよびアザキノリン化合物
WO2018013774A1 (en) 2016-07-14 2018-01-18 Bristol-Myers Squibb Company Bicyclic heteroaryl substituted compounds
CN111440146B (zh) * 2020-05-15 2022-10-21 中国药科大学 一种具有par4拮抗活性的苯并三嗪类化合物及其应用
CN117285527A (zh) * 2023-09-25 2023-12-26 中国药科大学 一种噌啉类par4拮抗剂及其医药应用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1164459A (en) * 1980-11-11 1984-03-27 Yung-Hsiung Yang Process for preparing (imidazo¬1,2-a|pyridine- 2-yl)-carbostyril or -3,4-dihydrocarbostyryl derivatives
TW279162B (enExample) * 1991-09-26 1996-06-21 Mitsubishi Chem Corp
JP2928079B2 (ja) 1994-02-14 1999-07-28 永信薬品工業股▲ふん▼有限公司 1−(置換ベンジル)−3−(置換アリール)縮合ピラゾール類、その製造法及びその用途
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6387942B2 (en) 2000-06-19 2002-05-14 Yung Shin Pharmaceutical Ind. Co. Ltd Method of treating disorders related to protease-activated receptors-induced cell activation
EP1348701A1 (en) 2002-03-28 2003-10-01 Warner-Lambert Company LLC (2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors
CA2534649A1 (en) 2003-08-01 2005-02-10 Genelabs Technologies, Inc. Bicyclic imidazol derivatives against flaviviridae
US20050272784A1 (en) 2004-05-07 2005-12-08 Xiaobing Li Inhibitors of bacterial Type III protein secretion systems
JP2008508314A (ja) 2004-07-28 2008-03-21 アイアールエム・リミテッド・ライアビリティ・カンパニー ステロイドホルモン核内受容体のモジュレーターとしての化合物および組成物
US20060211698A1 (en) 2005-01-14 2006-09-21 Genelabs, Inc. Bicyclic heteroaryl derivatives for treating viruses
US20080015193A1 (en) 2006-06-20 2008-01-17 Mendoza Jose S Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof
CN101479249B (zh) 2006-06-29 2012-10-10 霍夫曼-拉罗奇有限公司 苯并咪唑衍生物、其制备方法、它们作为fxr激动剂的用途及含有它们的药物制剂
WO2008073451A2 (en) 2006-12-11 2008-06-19 Sirtris Pharmaceuticals, Inc. Benzoimidazole derivatives as sirtuin (sir) modulating compounds
WO2009073497A2 (en) 2007-11-30 2009-06-11 Smithkline Beecham Corporation Prolyl hydroxylase inhibitors
EA021938B1 (ru) 2008-05-01 2015-10-30 Сертрис Фармасьютикалз, Инк. Хинолины и их аналоги в качестве модуляторов сиртуина
JP5351254B2 (ja) 2008-05-23 2013-11-27 ノバルティス アーゲー キノキサリン−およびキノリン−カルボキシアミド誘導体
CN102131809A (zh) 2008-07-23 2011-07-20 沃泰克斯药物股份有限公司 三环吡唑并吡啶激酶抑制剂
US20130072473A1 (en) 2011-05-09 2013-03-21 Proteostasis Therapeutics, Inc. Compounds for treating protein folding disorders
US9394297B2 (en) 2012-02-28 2016-07-19 Amgen Inc. Amides as pim inhibitors
EP2855489B1 (en) * 2012-04-26 2017-01-04 Bristol-Myers Squibb Company Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
EA201491967A1 (ru) 2012-04-26 2015-03-31 Бристол-Майерс Сквибб Компани Производные имидазотиадиазола в качестве ингибиторов активируемых протеазой рецепторов 4 (par4) для лечения агрегации тромбоцитов
SMT201700457T1 (it) 2012-04-26 2017-11-15 Bristol Myers Squibb Co DERlVATI IMIDAZOTIADIAZOLICI E IMIDAZOPIRAZINICI COME INIBITORI DEL RECETTORE ATTIVATO DA PROTEASI 4 (PAR4) PER IL TRATTAMENTO DELL'AGGREGAZIONE PIASTRINICA
WO2015077550A1 (en) * 2013-11-22 2015-05-28 University Of Kentucky Research Foundation Arylquinoline and analog compounds and use thereof to treat cancer
US9598419B1 (en) 2014-06-24 2017-03-21 Universite De Montreal Imidazotriazine and imidazodiazine compounds
US9617279B1 (en) 2014-06-24 2017-04-11 Bristol-Myers Squibb Company Imidazooxadiazole compounds
ES2929208T3 (es) 2015-02-26 2022-11-25 Univ Montreal Compuestos de imidazotiadiazol como inhibidores de PAR4
WO2016138199A1 (en) 2015-02-26 2016-09-01 Bristol-Myers Squibb Company Benzothiazole and benzothiophne compounds
KR20180030913A (ko) 2015-07-30 2018-03-26 브리스톨-마이어스 스큅 컴퍼니 아릴 치환된 비시클릭 헤테로아릴 화합물
JP7102388B2 (ja) 2016-07-14 2022-07-19 ブリストル-マイヤーズ スクイブ カンパニー 単環式ヘテロアリール置換化合物
WO2018013774A1 (en) * 2016-07-14 2018-01-18 Bristol-Myers Squibb Company Bicyclic heteroaryl substituted compounds
JP6903732B2 (ja) 2016-07-14 2021-07-14 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company Par4阻害剤としての三環式ヘテロアリール置換のキノリンおよびアザキノリン化合物
US10730868B2 (en) 2016-07-14 2020-08-04 Bristol-Myers Squibb Company Bicyclic heteroaryl substituted compounds

Similar Documents

Publication Publication Date Title
JP2019528247A5 (enExample)
JP4638355B2 (ja) チアゾール誘導体
US8129394B2 (en) Heteroaryl-substituted imidazole compounds and uses thereof
US20130109682A1 (en) Cyclic ether compounds useful as kinase inhibitors
US8865732B2 (en) Heterocyclic compounds and uses thereof
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
US9181272B2 (en) Aldosterone synthase inhibitors
AR073900A1 (es) Compuestos de espiro-oxindol y su uso como agentes terapeuticos.
RU2014152625A (ru) Конденсированные с гетероарилкетонами азадекалины - модуляторы глюкокортикоидных рецепторов
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
CA3118934A1 (en) Pyridazinone compounds and uses thereof
RU2020124138A (ru) Производные аминопиридина в качестве ингибиторов фосфатидилинозитолфосфаткиназы
RU2017120859A (ru) Замещенные мостиковые аналоги мочевины в качестве модуляторов сиртуина
RU2005123484A (ru) Новые производные пиридазин-3(2н)-она
JP2010524970A5 (enExample)
JP2015528022A5 (enExample)
JP2018530591A5 (enExample)
JP2013545744A5 (enExample)
WO2014062667A1 (en) Phenyl linked quinolinyl modulators of ror-gamma-t
JP2019521153A5 (enExample)
JP2015521999A5 (enExample)
JP2018508553A5 (enExample)
JP2019527215A5 (enExample)
JP2018521119A5 (enExample)
JP2018522062A5 (enExample)